Advancements in Stroke Care, Ischemic Stroke, and Cerebral Hemorrhages: Matthew Schrag, MD, PhD
The associate professor of neurology at Vanderbilt University Medical Center discussed the progress in stroke care, focusing on ischemic strokes and cerebral hemorrhages, and their connection with vascular diseases and cognitive disorders. [WATCH TIME: 3 minutes]
WATCH TIME: 3 minutes
“Stroke is a rather diverse set of diseases and to really understand it, we have to talk about ischemic strokes. In ischemic stroke, there has been this stampede of progress over the last decade with the emergence of thrombectomy and other interventional techniques to try to improve acute stroke care. Our ability to intervene and help patients is just advancing at a remarkable rate.”
The most common type of stroke among patients is ischemic stroke, which has threatened the life of patients and their health, ultimately. Through advances in research, the most mainstream method of treatment for patients with this condition is intravenous thrombolysis and endovascular thrombectomy.1 These newer advancements to the field have shown promise for improving health outcomes in patients with even more new emerging therapeutic interventions on the horizon.
Matthew Schrag, MD, PhD, associate professor of neurology at Vanderbilt University Medical Center, presented a talk session about neurovascular disorders at the 2023 International Congress on the Future of Neurology (IFN) annual meeting, held September 22-23, in Jersey City, New Jersey. In his presentation, he specifically spoke about the progress in ischemic stroke prevention and the recent advancements in poststroke care.
Prior to his talk, Schrag sat down in an interview with NeurologyLive® to discuss the recent developments such as thrombectomy and artificial intelligence (AI) integration that has helped to transform acute ischemic stroke treatment. He also spoke about the emerging signs of progress in clinical trials related to acute interest cerebral hemorrhage treatment. In addition, Schrag emphasized the connection between blood vessel disorders and cognitive conditions like Alzheimer disease.
Click here for more coverage on IFN 2023.
